FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116727306> ?p ?o ?g. }

• W2116727306 endingPage "2074" @default.
• W2116727306 startingPage "2069" @default.
• W2116727306 abstract "Impaired insulin-mediated hepatic glucose uptake (HGU) has been implicated in the hyperglycemia of type 2 diabetes. We examined the effects of metformin (2 g/day) and rosiglitazone (8 mg/day) monotherapy on HGU and its relation to subcutaneous fat, visceral fat (VF), and whole-body insulin-mediated glucose metabolism in type 2 diabetic patients.Glucose uptake was measured before and after 26 weeks of treatment using positron emission tomography with [(18)F]2-fluoro-2-deoxyglucose during euglycemic hyperinsulinemia; fat depots were quantified by magnetic resonance imaging.Fasting plasma glucose levels were significantly decreased after either rosiglitazone (-0.9 +/- 0.5 mmol/l) or metformin treatment (-1.1 +/- 0.5 mmol/l) in comparison with placebo; only metformin was associated with weight loss (P < 0.02 vs. placebo). When controlling for the latter, the placebo-subtracted change in whole-body glucose uptake averaged -1 +/- 4 micromol x min(-1) x kg(-1) in metformin-treated patients (NS) and +9 +/- 3 micromol x min(-1) x kg(-1) in rosiglitazone-treated patients (P = 0.01). Both rosiglitazone and metformin treatment were associated with an increase in HGU; versus placebo, the change reached statistical significance when controlling for sex (placebo-subtracted values = +0.008 +/- 0.004 micromol x min(-1) x kg(-1) x pmol/l(-1), P < 0.03, for metformin; and +0.007 +/- 0.004, P < 0.07, for rosiglitazone). After treatment with either drug, insulin-mediated VF glucose uptake (VFGU) was higher than with placebo. In the whole dataset, changes in HGU were negatively related to changes in HbA(1c) (r = 0.43, P = 0.01) and positively associated with changes in VFGU (r = 0.48, P < 0.01).We conclude that both metformin and rosiglitazone monotherapy increase HGU in type 2 diabetes; direct drug actions, better glycemic control, and enhanced VF insulin sensitivity are likely determinants of this phenomenon." @default.
• W2116727306 created "2016-06-24" @default.
• W2116727306 creator A5006418280 @default.
• W2116727306 creator A5018187554 @default.
• W2116727306 creator A5026147553 @default.
• W2116727306 creator A5028878666 @default.
• W2116727306 creator A5038203474 @default.
• W2116727306 creator A5040337251 @default.
• W2116727306 creator A5049804910 @default.
• W2116727306 creator A5065855094 @default.
• W2116727306 creator A5070124449 @default.
• W2116727306 creator A5071018999 @default.
• W2116727306 creator A5089847244 @default.
• W2116727306 date "2003-07-01" @default.
• W2116727306 modified "2023-09-30" @default.
• W2116727306 title "Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes" @default.
• W2116727306 cites W1676164379 @default.
• W2116727306 cites W2018568241 @default.
• W2116727306 cites W2022649084 @default.
• W2116727306 cites W2033550999 @default.
• W2116727306 cites W2051228374 @default.
• W2116727306 cites W2061128544 @default.
• W2116727306 cites W2071942541 @default.
• W2116727306 cites W2074545234 @default.
• W2116727306 cites W2075369262 @default.
• W2116727306 cites W2077178297 @default.
• W2116727306 cites W2079916975 @default.
• W2116727306 cites W2090306035 @default.
• W2116727306 cites W2095838561 @default.
• W2116727306 cites W2100514340 @default.
• W2116727306 cites W2105912552 @default.
• W2116727306 cites W2134293572 @default.
• W2116727306 cites W2138226825 @default.
• W2116727306 cites W2141065273 @default.
• W2116727306 cites W2144838695 @default.
• W2116727306 cites W2146118393 @default.
• W2116727306 cites W2154271176 @default.
• W2116727306 cites W2155488115 @default.
• W2116727306 cites W2157573823 @default.
• W2116727306 cites W2168023849 @default.
• W2116727306 cites W4247421067 @default.
• W2116727306 doi "https://doi.org/10.2337/diacare.26.7.2069" @default.
• W2116727306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12832315" @default.
• W2116727306 hasPublicationYear "2003" @default.
• W2116727306 type Work @default.
• W2116727306 sameAs 2116727306 @default.
• W2116727306 citedByCount "58" @default.
• W2116727306 countsByYear W21167273062012 @default.
• W2116727306 countsByYear W21167273062013 @default.
• W2116727306 countsByYear W21167273062014 @default.
• W2116727306 countsByYear W21167273062015 @default.
• W2116727306 countsByYear W21167273062016 @default.
• W2116727306 countsByYear W21167273062017 @default.
• W2116727306 countsByYear W21167273062019 @default.
• W2116727306 countsByYear W21167273062020 @default.
• W2116727306 countsByYear W21167273062021 @default.
• W2116727306 countsByYear W21167273062022 @default.
• W2116727306 crossrefType "journal-article" @default.
• W2116727306 hasAuthorship W2116727306A5006418280 @default.
• W2116727306 hasAuthorship W2116727306A5018187554 @default.
• W2116727306 hasAuthorship W2116727306A5026147553 @default.
• W2116727306 hasAuthorship W2116727306A5028878666 @default.
• W2116727306 hasAuthorship W2116727306A5038203474 @default.
• W2116727306 hasAuthorship W2116727306A5040337251 @default.
• W2116727306 hasAuthorship W2116727306A5049804910 @default.
• W2116727306 hasAuthorship W2116727306A5065855094 @default.
• W2116727306 hasAuthorship W2116727306A5070124449 @default.
• W2116727306 hasAuthorship W2116727306A5071018999 @default.
• W2116727306 hasAuthorship W2116727306A5089847244 @default.
• W2116727306 hasBestOaLocation W21167273061 @default.
• W2116727306 hasConcept C126322002 @default.
• W2116727306 hasConcept C134018914 @default.
• W2116727306 hasConcept C142724271 @default.
• W2116727306 hasConcept C17093226 @default.
• W2116727306 hasConcept C204787440 @default.
• W2116727306 hasConcept C27081682 @default.
• W2116727306 hasConcept C2776923340 @default.
• W2116727306 hasConcept C2777180221 @default.
• W2116727306 hasConcept C2777391703 @default.
• W2116727306 hasConcept C2777866211 @default.
• W2116727306 hasConcept C2779306644 @default.
• W2116727306 hasConcept C2780152017 @default.
• W2116727306 hasConcept C2780323712 @default.
• W2116727306 hasConcept C2780988686 @default.
• W2116727306 hasConcept C555293320 @default.
• W2116727306 hasConcept C71924100 @default.
• W2116727306 hasConceptScore W2116727306C126322002 @default.
• W2116727306 hasConceptScore W2116727306C134018914 @default.
• W2116727306 hasConceptScore W2116727306C142724271 @default.
• W2116727306 hasConceptScore W2116727306C17093226 @default.
• W2116727306 hasConceptScore W2116727306C204787440 @default.
• W2116727306 hasConceptScore W2116727306C27081682 @default.
• W2116727306 hasConceptScore W2116727306C2776923340 @default.
• W2116727306 hasConceptScore W2116727306C2777180221 @default.
• W2116727306 hasConceptScore W2116727306C2777391703 @default.
• W2116727306 hasConceptScore W2116727306C2777866211 @default.
• W2116727306 hasConceptScore W2116727306C2779306644 @default.
• W2116727306 hasConceptScore W2116727306C2780152017 @default.

• next